- Supported exchanges /
- NASDAQ /
- CDIOW.NASDAQ
Cardio Diagnostics Holdings Inc (CDIOW NASDAQ) stock market data APIs
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings Inc Financial Data Overview
0.0315 | |
0.0282 | |
- | |
0.0315 | |
0.024 | |
0.024-0.275 | |
0 | |
0 | |
39 138 | |
4.814 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Cardio Diagnostics Holdings Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 39 138
- EBITDA -8 215 199
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Cardio Diagnostics Holdings Inc Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Cardio Diagnostics Holdings Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: